Trial intelligence / Profile preview

PEG Preparation for Video-Capsule Endoscopy in GI Bleeding

NCT01267981Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Sep 2010
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of polyethylene glycol 3350 + bisacodyl in gastrointestinal bleeding, sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Frequencies of the diagnoses of clinically significant lesions. Started Sep 2010; status: completed.

02

Drugs

polyethylene glycol 3350 + bisacodyl
03

Conditions

gastrointestinal bleeding

Beyond the preview

Go deeper on NCT01267981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01267981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call